Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
1998 | 1 |
1999 | 1 |
2003 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.
Adv Cancer Res. 1997;71:343-71. doi: 10.1016/s0065-230x(08)60103-7.
Adv Cancer Res. 1997.
PMID: 9111870
Review.
Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens.
Disis ML, Shiota FM, Cheever MA.
Disis ML, et al.
Immunology. 1998 Feb;93(2):192-9. doi: 10.1046/j.1365-2567.1998.00424.x.
Immunology. 1998.
PMID: 9616368
Free PMC article.
Item in Clipboard
Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens.
Disis ML, Shiota FM, McNeel DG, Knutson KL.
Disis ML, et al.
Immunobiology. 2003;207(3):179-86. doi: 10.1078/0171-2985-00230.
Immunobiology. 2003.
PMID: 12777059
Item in Clipboard
Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer.
Ward RL, Hawkins NJ, Coomber D, Disis ML.
Ward RL, et al.
Hum Immunol. 1999 Jun;60(6):510-5. doi: 10.1016/s0198-8859(99)00003-8.
Hum Immunol. 1999.
PMID: 10408800
Item in Clipboard
Cite
Cite